Cardiovascular Diagnostic Microfluidic Chip Development Services

Microfluidic chips are the leading of the new generation POCT technology, providing fast and effective on-site diagnostics directly to test samples. Ace Therapeutics can provide microfluidic chip development services that integrate a range of essential operating units involved in diagnostics for cardiovascular disease research to provide diagnostic development solutions for our clients.

Application of Microfluidic Chips in the Diagnostics of Cardiovascular Diseases

Cardiovascular diseases have a sudden onset and rapid progression. Therefore, timely diagnostics and assessment of cardiovascular disease progression are important for clinical management. Because microfluidics has the advantages of low sample consumption, high sensitivity, and automated analysis, it is ideally suited to studying complex cardiovascular biophysical interactions. Optical assays such as immunofluorescence, chemiluminescence, fluorescence resonance energy transfer (FRET) and surface-enhanced Raman scattering (SERS) are the main trends in the detection of biomarkers for cardiovascular diseases. Microfluidics has been combined with these optical assays to better diagnose cardiovascular diseases. Microfluidic-mediated immunofluorescence has also been applied together with cleavable label immunoassay (CTI) and micellar electrokinetic chromatography (MEKC) for the simultaneous detection and analysis of multiple cardiac biomarkers for the diagnosis of acute myocardial infarction.

Fig. 1 Microalgae viability analysis. (Alias AB, et al., 2022)

Microfluidics plays a crucial role in the biomedical fields of clinical diagnostic instruments and in vitro bionic models. Ace Therapeutics offers customized microfluidic chip development services, providing customers with professional solutions to meet their diagnostic development needs for cardiovascular diseases.

Microfluidic Chip Development Services We Can Offer

We can provide the following types of microfluidic chip development services:

Different Materials We Can Offer

Different Reaction Types We Can Offer

Different Detection Methods We Can Offer

Microfluidic Chip Development Progress

Ace Therapeutics is a leading developer of in vitro diagnostic platforms, providing diagnostic development services including high-performance IVD reagent development and microfluidic chip development solutions. If you are interested in our services, please don't hesitate to contact us.

1. Alias, A.B.; et al. Microfluidic Microalgae System: A Review. Molecules. 2022, 27(6): 1910.